RedHill Biopharma Ltd. (RDHL)

RedHill Biopharma Statistics

Total Valuation

RDHL has a market cap or net worth of $4.99 million. The enterprise value is $2.34 million.

Market Cap	4.99M
Enterprise Value	2.34M

Important Dates

The last earnings date was Friday, September 5, 2025, before market open.

Earnings Date	Sep 5, 2025
Ex-Dividend Date	n/a

Share Statistics

RDHL has 3.33 million shares outstanding. The number of shares has increased by 97.35% in one year.

Current Share Class	n/a
Shares Outstanding	3.33M
Shares Change (YoY)	+97.35%
Shares Change (QoQ)	+39.93%
Owned by Insiders (%)	0.59%
Owned by Institutions (%)	3.38%
Float	3.08M

Valuation Ratios

PE Ratio	n/a
Forward PE	n/a
PS Ratio	0.24
Forward PS	n/a
PB Ratio	n/a
P/TBV Ratio	n/a
P/FCF Ratio	n/a
P/OCF Ratio	n/a
PEG Ratio	n/a

Enterprise Valuation

EV / Earnings	n/a
EV / Sales	0.25
EV / EBITDA	n/a
EV / EBIT	n/a
EV / FCF	n/a

Financial Position

The company has a current ratio of 0.56

Current Ratio	0.56
Quick Ratio	0.37
Debt / Equity	n/a
Debt / EBITDA	n/a
Debt / FCF	n/a
Interest Coverage	n/a

Financial Efficiency

Return on Equity (ROE)	n/a
Return on Assets (ROA)	-25.32%
Return on Invested Capital (ROIC)	n/a
Return on Capital Employed (ROCE)	209.20%
Revenue Per Employee	$272,857
Profits Per Employee	-$266,086
Employee Count	35
Asset Turnover	0.47
Inventory Turnover	0.97

Taxes

Income Tax	n/a
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has decreased by -86.19% in the last 52 weeks. The beta is 4.24, so RDHL's price volatility has been higher than the market average.

Beta (5Y)	4.24
52-Week Price Change	-86.19%
50-Day Moving Average	1.57
200-Day Moving Average	3.36
Relative Strength Index (RSI)	54.75
Average Volume (20 Days)	88,263

Short Selling Information

Short Interest	76,513
Short Previous Month	57,343
Short % of Shares Out	3.75%
Short % of Float	n/a
Short Ratio (days to cover)	0.65

Income Statement

In the last 12 months, RDHL had revenue of $9.55 million and -$9.31 million in losses. Loss per share was -$6.02.

Revenue	9.55M
Gross Profit	6.16M
Operating Income	-8.18M
Pretax Income	23.92M
Net Income	-9.31M
EBITDA	-8.34M
EBIT	-8.18M
Loss Per Share	-$6.02

Balance Sheet

The company has $2.87 million in cash and $214,000 in debt, giving a net cash position of $2.65 million or $0.80 per share.

Cash & Cash Equivalents	2.87M
Total Debt	214,000
Net Cash	2.65M
Net Cash Per Share	$0.80
Equity (Book Value)	-4.41M
Book Value Per Share	-2.45
Working Capital	-9.73M

Cash Flow

In the last 12 months, operating cash flow was -$8.20 million and capital expenditures -$12,000, giving a free cash flow of -$8.21 million.

Operating Cash Flow	-8.20M
Capital Expenditures	-12,000
Free Cash Flow	-8.21M
FCF Per Share	-$2.47

Margins

Gross margin is 64.45%, with operating and profit margins of -85.70% and -97.52%.

Gross Margin	64.45%
Operating Margin	-85.70%
Pretax Margin	-97.52%
Profit Margin	-97.52%
EBITDA Margin	-87.29%
EBIT Margin	-85.70%
FCF Margin	n/a

Dividends & Yields

RDHL does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	-97.35%
Shareholder Yield	-97.35%
Earnings Yield	-186.45%
FCF Yield	-164.39%

Analyst Forecast

Price Target	n/a
Price Target Difference	n/a
Analyst Consensus	n/a
Analyst Count	n/a
Revenue Growth Forecast (5Y)	n/a
EPS Growth Forecast (5Y)	n/a

Fair Value

There are several formulas that can be used to estimate the intrinsic value of a stock.

Lynch Fair Value	n/a
Lynch Upside	n/a
Graham Number	n/a
Graham Upside	n/a

Stock Splits

The last stock split was on August 20, 2024. It was a reverse split with a ratio of 1:25.

Last Split Date	Aug 20, 2024
Split Type	Reverse
Split Ratio	1:25

Scores

RDHL has an Altman Z-Score of -33.23 and a Piotroski F-Score of 3. A Z-score under 3 suggests an increased risk of bankruptcy.

Altman Z-Score	-33.23
Piotroski F-Score	3